At the news
? BEARISHIMPACT 4/10 COURT-RULING filed Jun 15, 2026 at 20:00 ET
GSK was denied a motion to limit third-party deposition hours in its patent infringement cases against Pfizer/BioNTech and Moderna. A Special Master ruled that GSK failed to show good cause to restrict each defendant group to a combined 10 hours of depositions for key inventor witnesses, upholding the default seven-hour-per-party deposition standard. The decision is a procedural setback but not a merits ruling, it increases GSK's litigation burden and costs but does not affect the substantive patent claims.
- GSK sued Pfizer/BioNTech and Moderna for patent infringement relating to mRNA vaccine technology across three consolidated actions in Delaware.
- GSK sought to limit the defendants to a combined 10 hours of deposition time for key inventors Dr. Andrew Geall and Dr. Christian Mandl.
- The Special Master denied GSK's motion, finding no good cause to override the default seven-hour deposition per party under Rule 30(d)(1).
- Dr. Geall is named inventor on all eight patents asserted against Pfizer/BioNTech and is sole inventor on seven of those.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access